Breakthrough combo tested to awaken Brain-Injured patients
NCT ID NCT06052787
Summary
This study tested whether adding two medications, Cerebrolysin and Amantadine sulfate, to standard ICU care could help people recover better from a serious traumatic brain injury (TBI). It involved 150 adults with moderate to severe TBI. Researchers measured changes in consciousness, disability, and overall recovery over six weeks to see if the drug combination led to better outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRAUMATIC BRAIN INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faculty of medicine - Ain shams university
Cairo, Egypt
Conditions
Explore the condition pages connected to this study.